emu2 said:Great inovative lifesaving proven technology. Selling in Europe & improved Quality of life of many Bali burn vitems . I sold out profitably some months ago as Shares keep falling & intended to get back in as have faith based on published info. Hiccup with USA FDA fast track aproval. Reduced my buy orders from 17.5c to 16.5c & now .16c. Almost frightened this time that I'll get em now. Again someone knows something that we mug punters don't know. Market getting more like a Roulette wheel than investing with these small caps. "Sheesh". I'm in a Grouchy mood today Where are our Regulatory Authorities who are supposed to ask Questions.
DVEOUS said:I'm sitting on 60,000 CCE, bought 18 months ago at an avergae of 0.35.
Not impressed with the **** falling out of them since.
So much for reaching $1 by end of 2005.
Keen to hear comments too, as maybe I should accumulate more... or is this throwing away more good money?
Accaeric said:how can issue sp under SPP is 6.8c??? whammy...
Normally, sp will hit the issue price shortly... hopefully not the case in CCE
good luck to those of whom holding CCE.
booga82 said:Looked at this stock a while ago. The ReCell product is good. Several problems though. Its not approved in the US yet. Its expensive and not a life saving treatment as it is for burns to less than 2% of the body, so basically for aesthetic purposes. Which means it will be unlikely to make reimbursement lists. The FDA reviewed ReCell and asked for additional performance data before making its decision. they have to do a further clinical study so its not going to reach the US market for a while.
CellSpray and CellSpray XP are for larger scale burns but havent been approved in many major markets, again not in the US. The need for these products is quite small ie only treating patients in the thousands. Also not sure what the profit margin would be on these products. The cost of making these devices would be quite high.
cant really see any of these products being major money spinners. although the market cap is quite low these days. IMO most of the share price gain would have been made as the products were developed. if its falling even after all the approvals then i would steer clear. many other investment opportunities out there.
good luck.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?